Treatment success rate: XDR-TB cases in Americas (WHO region)

Americas (WHO region): Treatment success rate: XDR-TB cases was 61 in 2022. ▲ Rising

Latest (2022)
61
Change on year
down 14.1%
Rank
8th
of 11 groups
All-time high
71
in 2021
All-time low
12
in 2008
Years of data
15
2008–2022

Treatment success rate: XDR-TB cases in Americas (WHO region), 2008–2022

204060802008201520222008: 122009: 132010: 252011: 312012: 292013: 532014: 482015: 502016: 622017: 612018: 652019: 692020: 572021: 712022: 61

Source: World Health Organization, Global Health Observatory.

Analysis

In 2022, treatment success rate: xdr-tb cases in Americas (WHO region) stood at 61.

The figure is down 14.1% on the previous year and up 110.3% over ten years.

Over the whole period, treatment success rate: xdr-tb cases in Americas (WHO region) peaked at 71 in 2021 and was at its lowest, 12, in 2008.

The long-run direction has been consistently rising across the 15 years of available data.

Treatment success rate: XDR-TB cases in Americas (WHO region), year by year

Annual values for Treatment success rate: XDR-TB cases in Americas (WHO region), 2008 to 2022.
Year Value Change
2008 12
2009 13 +8.3%
2010 25 +92.3%
2011 31 +24.0%
2012 29 -6.5%
2013 53 +82.8%
2014 48 -9.4%
2015 50 +4.2%
2016 62 +24.0%
2017 61 -1.6%
2018 65 +6.6%
2019 69 +6.2%
2020 57 -17.4%
2021 71 +24.6%
2022 61 -14.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 12.5 12 13 2
2010s 49.3 25 69 10
2020s 63 57 71 3

More health data for Americas (WHO region)

All data for Americas (WHO region) →

Frequently asked questions

What is treatment success rate: xdr-tb cases in Americas (WHO region)?
Treatment success rate: xdr-tb cases in Americas (WHO region) was 61 in 2022, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate: xdr-tb cases recorded in Americas (WHO region)?
The highest recorded value was 71 in 2021.
What is the lowest treatment success rate: xdr-tb cases recorded in Americas (WHO region)?
The lowest recorded value was 12 in 2008.
How does Americas (WHO region) rank for treatment success rate: xdr-tb cases?
Americas (WHO region) ranks 8th out of 11 groups with data for 2022.
Is treatment success rate: xdr-tb cases rising or falling in Americas (WHO region)?
Over the last ten years it is up 110.3%. The long-run trend across the full record is rising.
Where does this Americas (WHO region) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: XDR-TB cases. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate: XDR-TB cases in Americas (WHO region). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 05 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-xdr-tb-cases/americas-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-xdr-tb-cases/americas-who-region/">Treatment success rate: XDR-TB cases in Americas (WHO region)</a> — Statizoid

About this data

Indicator
Treatment success rate: XDR-TB cases
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
93 places, 901 data points, 2008–2022
Last refreshed